Number of Shares
10.14 Mil
Current Holdings Value*
$207.54 Mil
% of Portfolio
3.47%
Total Estimate Gain
$73.28 Mil
% of Total Estimate Gain
47.12%

RA CAPITAL MANAGEMENT, L.P.'s NewAmsterdam Pharma Co NV Holding Summary

As of 2025-03-31, RA CAPITAL MANAGEMENT, L.P. held 10.14 Mil shares of NewAmsterdam Pharma Co NV(NAMS), totaling $207.54 Mil. This investment constitutes 3.47% of their stock portfolio, and RA CAPITAL MANAGEMENT, L.P. now holds 9.03% of the outstanding NewAmsterdam Pharma Co NV(NAMS) stock.

The initial trade took place in 2022Q4. And since then RA CAPITAL MANAGEMENT, L.P. has made 5 purchases of NAMS, at an average price of $13.79, for a total of 11.27 Mil shares. In addition, there have been 1 sales at an average price of $9.16 for 1.14 Mil shares. Based on historical transaction data and NAMS's current price of $21.54, RA CAPITAL MANAGEMENT, L.P.'s estimated gain on his NAMS holdings is $73.28 Mil, reflecting a 47.12% gain to date.

RA CAPITAL MANAGEMENT, L.P. NAMS ($21.54) Holding Chart

RA CAPITAL MANAGEMENT, L.P. NAMS ($21.54) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1